To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Perceptive Advisors-sponsored SPAC agrees to deal with Bain Capital-backed Cerevel Therapeutics
In addition to the $150m from Arya II, a group of healthcare investors committed to participate in the deal through a common stock private investment in public equity of about $320m at $10 per share.
